Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
12. Februar 2019 07:30 ET
|
Canntab Therapeutics Limited
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the development of precision oral dose cannabis tablets and capsules,...